Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals

American Journal of Hypertension

Volumn 26, Issue 10, 2013, Pages 1250-1255

  Miyaki, Asako ^a,b   Maeda, Seiji ^a   Choi, Youngju ^a,b   Akazawa, Nobuhiko ^a   Eto, Miki ^a   Tanaka, Kiyoji ^a   Ajisaka, Ryuichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

arterial stiffness; blood pressure; cardiovascular disease cardiovascular protection; hypertension; obesity; pentraxin 3

Indexed keywords

PENTRAXIN 3;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BLOOD CHEMISTRY; BODY MASS; BODY WEIGHT; BRACHIAL ANKLE PULSE WAVE VELOCITY; CAROTID ARTERY PULSE; CAROTID FEMORAL ARTERY PULSE WAVE VELOCITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEMORAL ARTERY; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; JAPANESE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RISK FACTOR; TONOMETRY;

ARTERIAL STIFFNESS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE CARDIOVASCULAR PROTECTION; HYPERTENSION; OBESITY; PENTRAXIN 3.;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PULSE WAVE ANALYSIS; SERUM AMYLOID P-COMPONENT; VASCULAR STIFFNESS;

EID: 84887622654     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt103     Document Type: Article

References (36)

1. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444:875-880
2. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97
3. Inadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 2008;29: 248-262
4. Ferrante AW. Obesity-induced inflammation: A metabolic dialogue in the language of inflammation. J Intern Med 2007;262:408-414
5. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949
6. Kondo T, Kobayashi I, Murakami M. Effect of exercise on circulating adipokine levels in obese young women. Endocr J 2006;53:189-195
7. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: Molecular links between obesity and atherosclerosis. Am J Physiol 2005;288:H2031-H2041
8. Safar ME, London GM. Therapeutic studies and arterial stiffness in hypertension: Recommendations of the European Society of Hypertension. The Clinical Committee of Arterial Structure and Function. J Hypertens 2000;18:1527-1535
9. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 2005;66:265-275
10. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005;46:1118-1122
11. Lilitkarntakul P, Dhaun N, Melville V, Blackwell S, Talwar DK, Liebman B, Asai T, Pollock J, Goddard J, Webb DJ. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity. Atherosclerosis 2011;246:2117-2125
12. Maki-Pataja KM, Hall FC, Booth AD, Wallace SM, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006;114:1185-1192
13. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997;96:3042-3047
14. Norata GD, Marchesi P, Krishna V, Venu P, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 2009;120:699-708
15. Salio M, Chimenti S, Angelis ND, Molla F, Maina V, Nebuloni M, Pasqualini F, Latini R, Garlanda C, Mantovani A. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008;117:1055-1064
16. Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA Tanaka H. Brachial-ankle pulse wave velocity: An index of central arterial stiffness? J Hum Hypertens 2005;19:401-406
17. Miyaki A, Maeda S, Otsuki T, Ajisaka R. Plasma pentraxin 3 concentration increases in endurance-trained men. Med Sci Sports Exerc 2011;43:12-17
18. Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002;22:e10-e14
19. Satoh H, Kishi R, Tsutsui H. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects. Hypertens Res 2009;32:1067-1071
20. Osorio-Conles O, Guitart M, Chacón MR, Maymo-Masip E, Moreno-Navarrete JM, Montori-Grau M, Näf S, Fernandez-Real JM, Vendrell J, Gómez-Foix AM. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity. Am J Physiol 2011;301:E1254-E1261
21. Chu SH, Park JH, Lee MK, Jekal Y, Ahn KY, Chung JY, Lee DH, Kim ES, Naruse M, Im JA, In DK, Chung CH, Lee JW, Chung KM, Kim YB, Jeon JY. The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention. Clin Chim Acta 2012;413:1430-1437
22. Miyaki A, Choi Y, Maeda S. Pentraxin 3 production in the adipose tissue and the skeletal muscle in diabetic-obese mice. Am J Med Sci 2013 doi:10.1097/MAJ.0b013e31828341af 23
23. Ogawa T, Kawano Y, Imamura T, Kawakita K, Sagara M, Matsuo T, Kakitsubata Y, Ishikawa T, Kitamura K, Hatakeyama K, Asada Y, Kodama T. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome. Obesity 2010;18: 1871-1874
24. Norata GD, Marchesi P, Pirillo A, Uboldi P, Chiesa G, Maina V, Garlanda C, Mantovani A, Catapano AL. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 2008;28:925-31
25. Ingelsson E, Sullivan LM, Fox CS, Murabito JM, Benjamin EJ, Polak JF, Meigs JB, Keyes MJ, O'Donnell CJ, Wang TJ, D'Agostino RB, Wolf PA, Vasan RS. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation 2007;116:375-384
26. Tsamis A, Stergiopulos N. Arterial remodeling in response to increased blood flow using a constituent-based model. J Biomech 2009;42:531-536
27. Bruel A, ørtoft G, Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis 1998;140:135-145
28. Oslon TP, Schmitz KH, Leon AS, Dengel DR. Vascular structure and function in women: Relationship with body mass index. Am J Prev Med 2006;30:487-492
29. Savoia C, Touyz RM, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008;51:432-439
30. Tanaka H, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000;102:1270-1275
31. Hansen F, Mangell P, Sonesson B, Lanne T. Diameter and compliance in the human common carotid artery-variations with age and sex. Ultrasound Med Biol 1995;21:1-9
32. Miyaki A, Maeda S, Yoshizawa M, Misono M, Saito Y, Sasai H, Endo T, Nakata Y, Tanaka K, Ajisaka R. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men. Angiology 2009;60:351-357
33. Miyaki A, Maeda S, Yoshizawa M, Misono M, Sasai H, Shimojo N, Tanaka K, Ajisaka R. Is pentraxin 3 involved in obesity-induced decrease in arterial distensibility? J Atheroscler Thromb 2010;17:278-284
34. Miyaki A, Maeda S, Choi Y, Akazawa N, Tanabe Y, Ajisaka R. Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women. Appl Physiol Nutr Metab 2012;37:907-911
35. Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001;29:1404-1407
36. Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ. Soluble TWEAK an PTX3 in nondialysis CKD patients: Impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol 2011;6:785-792